ARTICLE | Clinical News
S-555739: Phase IIb data
June 18, 2012 7:00 AM UTC
Top-line data from a Japanese Phase IIb trial showed that once-daily oral S-555739 in combination with an antihistamine met the co-primary endpoints of improving 3 undisclosed nasal symptoms of allerg...